Reuters reports that Purdue Pharma, the Stamford-based maker of OxyContin, is nearing an agreement with federal authorities to plead guilty to criminal charges. The plea would be part of a broader deal to resolve U.S. Justice Department investigations into its alleged role in fueling the nation’s opioid crisis. Reuters’ sources say the deal could be unveiled within two weeks, and would include billions of dollars in both criminal and civil penalties. Connecticut is one of the states that continues to pursue a case against Purdue over the costs of the opioid epidemic.
